Correction to: Trials (2020) 21:80
https://doi.org/10.1186/s13063-019-3965-4
After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.
Original name spelling:
Charlotte Flühe
Correct name spelling:
Charlotte Flüh
The original article has been corrected.
Reference
Tegtmeier, et al. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials. 2020;21:80. https://doi.org/10.1186/s13063-019-3965-4.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Tegtmeier, F., Schinzel, R., Beer, R. et al. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials 21, 172 (2020). https://doi.org/10.1186/s13063-020-4107-8
Published:
DOI: https://doi.org/10.1186/s13063-020-4107-8